KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $155,000 | +89.0% | 5,069 | +0.8% | 0.01% | +100.0% |
| Q2 2020 | $82,000 | +1950.0% | 5,029 | +1126.6% | 0.01% | – |
| Q1 2020 | $4,000 | -89.2% | 410 | -84.7% | 0.00% | -100.0% |
| Q4 2019 | $37,000 | -19.6% | 2,687 | -10.6% | 0.00% | -33.3% |
| Q3 2019 | $46,000 | +21.1% | 3,007 | +55.5% | 0.00% | 0.0% |
| Q2 2019 | $38,000 | +216.7% | 1,934 | +164.9% | 0.00% | +200.0% |
| Q1 2019 | $12,000 | -33.3% | 730 | -41.4% | 0.00% | -50.0% |
| Q4 2018 | $18,000 | -21.7% | 1,245 | -7.0% | 0.00% | 0.0% |
| Q3 2018 | $23,000 | -99.4% | 1,339 | +508.6% | 0.00% | – |
| Q2 2018 | $4,004,000 | +33266.7% | 220 | -68.2% | 0.00% | -100.0% |
| Q1 2018 | $12,000 | +500.0% | 691 | +785.9% | 0.00% | – |
| Q4 2017 | $2,000 | -33.3% | 78 | -65.3% | 0.00% | – |
| Q3 2017 | $3,000 | – | 225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |